MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
04 Maio 2023 - 5:30PM
MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
focused on developing and commercializing innovative monoclonal
antibody-based therapeutics for the treatment of cancer, today
announced that the Company will release its financial results for
the first quarter of 2023 after the market closes on Tuesday, May
9, 2023. MacroGenics will host a conference call to discuss the
financial results and recent corporate progress on Tuesday, May 9,
2023, at 4:30 pm ET.
Conference Call Information
To participate via telephone, please register in advance via
this link. Upon registration, all telephone participants will
receive a confirmation email detailing how to join the conference
call, including the dial-in number along with a unique passcode and
registrant ID that can be used to access the call. The listen-only
webcast of the conference call can be accessed under "Events &
Presentations" in the Investor Relations section of the Company's
website at http://ir.macrogenics.com/events.cfm. A recorded replay
of the webcast will be available shortly after the conclusion of
the call and archived on the Company's website for 30 days
following the call.
About MacroGenics, Inc.
MacroGenics is a biopharmaceutical company focused on developing
and commercializing innovative monoclonal antibody-based
therapeutics for the treatment of cancer. The Company generates its
pipeline of product candidates primarily from its proprietary suite
of next-generation antibody-based technology platforms, which have
applicability across broad therapeutic domains. The combination of
MacroGenics' technology platforms and protein engineering expertise
has allowed the Company to generate promising product candidates
and enter into several strategic collaborations with global
pharmaceutical and biotechnology companies. For more information,
please see the Company's website at www.macrogenics.com.
MacroGenics and the MacroGenics logo are trademarks or registered
trademarks of MacroGenics, Inc.
###
CONTACTS:
Jim Karrels, Senior Vice President, CFO
1-301-251-5172, info@macrogenics.com
MacroGenics (NASDAQ:MGNX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
MacroGenics (NASDAQ:MGNX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024